{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:59:01Z","timestamp":1780469941906,"version":"3.54.1"},"reference-count":336,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fund \u201cNauka\u201d at the Medical University of Varna, Bulgaria","award":["20016"],"award-info":[{"award-number":["20016"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>In the preceding and early stages of cancer progression, local drug delivery to pre-cancerous and cancerous skin lesions may be applied as an alternative or supplementary therapy. At present, 5-Fluorouracil, imiquimod, and tirbanibulin creams and ointments have established their place in practice, while several other active pharmaceutical ingredients (APIs) (e.g., calcipotriol, tretinoin, diclofenac) have been repurposed, used off-label, or are currently being investigated in mono- or combined chemotherapies of skin cancers. Apart from them, dozens to hundreds of therapeutics of natural and synthetic origin are proven to possess anti-tumor activity against melanoma, squamous cell carcinoma (SCC), and other skin cancer types in in vitro studies. Their clinical introduction is most often limited by low skin permeability, challenged targeted drug delivery, insufficient chemical stability, non-selective cytotoxicity, or insufficient safety data. A variety of prodrug and nanotechnological approaches, including vesicular systems, micro- and nanoemulsions, solid lipid nanoparticles, nanostructured lipid carriers, polymeric nanoparticles, and others, offer versatile solutions for overcoming the biophysical barrier function of the skin and the undesirable physicochemical nature of some drug molecules. This review aims to present the most significant aspects and latest achievements on the subject.<\/jats:p>","DOI":"10.3390\/pharmaceutics17081009","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T09:41:17Z","timestamp":1754300477000},"page":"1009","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Local Chemotherapy of Skin Pre-Neoplastic Lesions and Malignancies from the Perspective of Current Pharmaceutics"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0226-2170","authenticated-orcid":false,"given":"Nadezhda","family":"Ivanova","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Technologies, Faculty of Pharmacy, Medical University of Varna, 9000 Varna, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cpt.2024.08.002","article-title":"Overview of skin cancer types and prevalence rates across continents","volume":"3","author":"Roky","year":"2024","journal-title":"Cancer Pathog. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jdin.2023.07.003","article-title":"Aging trends in skin cancer: A long-term observational study in Japan","volume":"13","author":"Nakamura","year":"2023","journal-title":"JAAD Int."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Saginala, K., Barsouk, A., Aluru, J.S., Rawla, P., and Barsouk, A. (2021). Epidemiology of Melanoma. Med. Sci., 9.","DOI":"10.3390\/medsci9040063"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1080\/15384047.2019.1640032","article-title":"Current state of melanoma diagnosis and treatment","volume":"20","author":"Davis","year":"2019","journal-title":"Cancer Biol. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12943-022-01708-4","article-title":"Advancements in nanoparticle-based treatment approaches for skin cancer therapy","volume":"22","author":"Zeng","year":"2023","journal-title":"Mol. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Attal, Z.G., Shalata, W., Soklakova, A., Tourkey, L., Shalata, S., Abu Saleh, O., Abu Salamah, F., Alatawneh, I., and Yakobson, A. (2024). Advanced and Metastatic Non-Melanoma Skin Cancer: Epidemiology, Risk Factors, Clinical Features, and Treatment Options. Biomedicines, 12.","DOI":"10.3390\/biomedicines12071448"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1017\/S0022215116000554","article-title":"Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines","volume":"130","author":"Newlands","year":"2016","journal-title":"J. Laryngol. Otol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12935-023-03012-7","article-title":"Current status of skin cancers with a focus on immunology and immunotherapy","volume":"23","author":"Sarkesh","year":"2023","journal-title":"Cancer Cell Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"108535","DOI":"10.1016\/j.envint.2024.108535","article-title":"Current insights and future perspectives of ultraviolet radiation (UV) exposure: Friends and foes to the skin and beyond the skin","volume":"185","author":"Tang","year":"2024","journal-title":"Environ. Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.pbiomolbio.2006.02.009","article-title":"The mechanisms and consequences of ultraviolet-induced immunosuppression","volume":"92","author":"Norval","year":"2006","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Liu, H.M., Cheng, M.Y., Xun, M.H., Zhao, Z.W., Zhang, Y., Tang, W., Cheng, J., Ni, J., and Wang, W. (2023). Possible Mechanisms of Oxidative Stress-Induced Skin Cellular Senescence, Inflammation, and Cancer and the Therapeutic Potential of Plant Polyphenols. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043755"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Rahman, I. (2006). Oxidative Stress in the Pathogenesis of Chronic Obstructive Pulmonary Disease. Cigarette Smoke and Oxidative Stress, Springer.","DOI":"10.1007\/3-540-32232-9_6"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Adnan, M., Akhter, M.H., Afzal, O., Altamimi, A.S.A., Ahmad, I., Alossaimi, M.A., Jaremko, M., Emwas, A.-H., Haider, T., and Haider, M.F. (2023). Exploring Nanocarriers as Treatment Modalities for Skin Cancer. Molecules, 28.","DOI":"10.3390\/molecules28155905"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Prohic, A. (2024). Precancerous Skin Lesions. Dermatovenerology Textbook, Springer.","DOI":"10.1007\/978-3-031-66131-0"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e15842","DOI":"10.1111\/dth.15842","article-title":"Complementary and alternative therapies in skin cancer: A literature review of biologically active compounds","volume":"35","author":"Hidalgo","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"100068","DOI":"10.1016\/j.ntm.2024.100068","article-title":"Nanocarriers in skin cancer treatment: Emerging drug delivery approaches and innovations","volume":"4","author":"Jadhav","year":"2025","journal-title":"Nano TransMed"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"100197","DOI":"10.1016\/j.xjidi.2023.100197","article-title":"Nanoparticles as a Therapeutic Delivery System for Skin Cancer Prevention and Treatment","volume":"3","author":"Chang","year":"2023","journal-title":"JID Innov."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/978-3-0348-0837-8_17","article-title":"The role of inflammation in skin cancer","volume":"816","author":"Maru","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1365-2133.2011.10507.x","article-title":"Roles of the immune system in skin cancer","volume":"165","author":"Rangwala","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12957-023-03084-9","article-title":"Management of complications after skin surgery relevant for melanoma in the trunk and extremities during the COVID-19 pandemic: A case series report","volume":"21","author":"Huang","year":"2023","journal-title":"World J. Surg. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"112819","DOI":"10.1016\/j.eurpolymj.2024.112819","article-title":"Nanotherapeutic approaches for transdermal drug delivery systems and their biomedical applications","volume":"207","author":"Khan","year":"2024","journal-title":"Eur. Polym. J."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Leong, M.Y., Kong, Y.L., Burgess, K., Wong, W.F., Sethi, G., and Looi, C.Y. (2023). Recent development of nanomaterials for transdermal drug delivery. Biomedicines, 11.","DOI":"10.3390\/biomedicines11041124"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"157668","DOI":"10.1016\/j.cej.2024.157668","article-title":"Photoprotective and bioinspired cerium-encapsulating lignin nanocapsules for multifunctional UV protection applications","volume":"501","author":"Mearaj","year":"2024","journal-title":"Chem. Eng. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/NSA.S19419","article-title":"Titanium dioxide and zinc oxide nanoparticles in sunscreens: Focus on their safety and effectiveness","volume":"4","author":"Smijs","year":"2011","journal-title":"Nanotechnol. Sci. Appl."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0022-4596(02)00139-1","article-title":"Cerium oxide for sunscreen cosmetics","volume":"171","author":"Yabe","year":"2003","journal-title":"J. Solid. State Chem."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Brito, S., Baek, M., and Bin, B.-H. (2024). Skin Structure, Physiology, and Pathology in Topical and Transdermal Drug Delivery. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16111403"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.jid.2016.11.045","article-title":"Human Skin Is the Largest Epithelial Surface for Interaction with Microbes","volume":"137","author":"Gallo","year":"2017","journal-title":"J. Investig. Dermatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jtherbio.2016.06.017","article-title":"Thermoelastic Modelling of the Skin at Finite Deformations","volume":"62","author":"McBride","year":"2016","journal-title":"J. Therm. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"8239","DOI":"10.3390\/cimb46080487","article-title":"Skin Development and Disease: A Molecular Perspective","volume":"46","author":"Dermitzakis","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Luki\u0107, M., Panteli\u0107, I., and Savi\u0107, S.D. (2021). Towards Optimal pH of the Skin and Topical Formulations: From the Current State of the Art to Tailored Products. Cosmetics, 8.","DOI":"10.3390\/cosmetics8030069"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Kuo, S.-H., Shen, C.-J., Shen, C.-F., and Cheng, C.-M. (2020). Role of pH Value in Clinically Relevant Diagnosis. Diagnostics, 10.","DOI":"10.3390\/diagnostics10020107"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Sanchez, M.M., Tonmoy, T.I., Park, B.H., and Morgan, J.T. (2022). Development of a Vascularized Human Skin Equivalent with Hypodermis for Photoaging Studies. Biomolecules, 12.","DOI":"10.3390\/biom12121828"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1038\/jid.2012.246","article-title":"Structure and Function of the Stratum Corneum Extracellular Matrix","volume":"132","author":"Elias","year":"2012","journal-title":"J. Investig. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Santiago, J.L., Mu\u00f1oz-Rodriguez, J.R., Cruz-Morcillo, M.A.d.l., Villar-Rodriguez, C., Gonzalez-Lopez, L., Aguado, C., Nuncia-Cantarero, M., Redondo-Calvo, F.J., Perez-Ortiz, J.M., and Galan-Moya, E.M. (2021). Characterization of Permeability Barrier Dysfunction in a Murine Model of Cutaneous Field Cancerization Following Chronic UV-B Irradiation: Implications for the Pathogenesis of Skin Cancer. Cancers, 13.","DOI":"10.3390\/cancers13163935"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Ishitsuka, Y., and Roop, D.R. (2020). Loricrin: Past, Present, and Future. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21072271"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Fujii, M. (2021). The Pathogenic and Therapeutic Implications of Ceramide Abnormalities in Atopic Dermatitis. Cells, 10.","DOI":"10.3390\/cells10092386"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3390\/pharmaceutics7040438","article-title":"Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the Stratum Corneum","volume":"7","author":"Alkilani","year":"2015","journal-title":"Pharmaceutics"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jconrel.2024.01.036","article-title":"Skin Electroporation for Transdermal Drug Delivery: Electrical Measurements, Numerical Model and Molecule Delivery","volume":"367","author":"Kougkolos","year":"2024","journal-title":"J. Control Release"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Og\u00f3rek, K., Nowak, K., Wadych, E., Ruzik, L., Timerbaev, A.R., and Matczuk, M. (2025). Are We Ready to Measure Skin Permeation of Modern Antiaging GHK\u2013Cu Tripeptide Encapsulated in Liposomes?. Molecules, 30.","DOI":"10.3390\/molecules30010136"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s13346-021-00909-6","article-title":"Enhancement Strategies for Transdermal Drug Delivery Systems: Current Trends and Applications","volume":"12","author":"Ramadon","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_41","first-page":"1","article-title":"Transfollicular Drug Delivery: Current Perspectives","volume":"5","author":"Jain","year":"2016","journal-title":"Res. Rep. Transdermal Drug Deliv."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2005.09.025","article-title":"Transfollicular Drug Delivery\u2014Is it a Reality?","volume":"306","author":"Meidan","year":"2005","journal-title":"Int. J. Pharm."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"875","DOI":"10.4155\/tde.14.56","article-title":"Getting Under the Skin: What Is the Potential of the Transfollicular Route in Drug Delivery?","volume":"5","author":"Rancan","year":"2014","journal-title":"Ther. Deliv."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/srt.12968","article-title":"Methods for Evaluating Penetration of Drug into the Skin: A Review","volume":"27","author":"Supe","year":"2020","journal-title":"Ski. Res. Technol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cocis.2012.02.001","article-title":"Penetration of Drugs through Skin, A Complex Rate-controlling Membrane","volume":"17","author":"Bolzinger","year":"2012","journal-title":"Curr. Opin. Colloid. Interface Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/wound.2011.0356","article-title":"Characteristics of the Aging Skin","volume":"2","author":"Farage","year":"2013","journal-title":"Adv. Wound Care"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.ajpath.2020.03.007","article-title":"The Pathobiology of Skin Aging: New Insights into an Old Dilemma","volume":"190","author":"Murphy","year":"2020","journal-title":"Am. J. Pathol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.18632\/aging.102946","article-title":"Aging-associated alterations in epidermal function and their clinical significance","volume":"12","author":"Wang","year":"2020","journal-title":"Aging"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.clindermatol.2010.07.005","article-title":"Dry skin in the elderly: Complexities of a common problem","volume":"29","author":"Reddy","year":"2011","journal-title":"Clin. Dermatol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Ribeiro, M., Sim\u00f5es, M., Vitorino, C., and Mascarenhas-Melo, F. (2024). Hydrogels in Cutaneous Wound Healing: Insights into Characterization, Properties, Formulation and Therapeutic Potential. Gels, 10.","DOI":"10.3390\/gels10030188"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e08938","DOI":"10.1016\/j.heliyon.2022.e08938","article-title":"Physicochemical and Biopharmaceutical Aspects Influencing Skin Permeation and Role of SLN and NLC for Skin Drug Delivery","volume":"8","author":"Souto","year":"2022","journal-title":"Heliyon"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1523-1747.2005.23726.x","article-title":"Stratum Corneum Moisturization at the Molecular Level: An Update in Relation to the Dry Skin Cycle","volume":"124","author":"Rawlings","year":"2005","journal-title":"J. Investig. Dermatol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Za\u0142\u0119cki, P., Rogowska, K., W\u0105s, P., \u0141uczak, K., Wysocka, M., and Nowicka, D. (2024). Impact of Lifestyle on Differences in Skin Hydra-Tion of Selected Body Areas in Young Women. Cosmetics, 11.","DOI":"10.3390\/cosmetics11010013"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Gidado, I., Qassem, M., Triantis, I., and Kyriacou, P. (2022). Review of Advances in the Measurement of Skin Hydration Based on Sensing of Optical and Electrical Tissue Properties. Sensors, 22.","DOI":"10.3390\/s22197151"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/jdv.13707","article-title":"Ambient Humidity and the Skin: The Impact of Air Humidity in Healthy and Diseased States","volume":"30","author":"Goad","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Walters, K., and Lane, M. (2020). Dermal and Transdermal Drug Delivery Systems. Dermal Drug Delivery, CRC Press.","DOI":"10.1201\/9781315374215-1"},{"key":"ref_57","first-page":"e38961","article-title":"Comprehensive Overview of Skin Complications in Diabetes and Their Prevention","volume":"15","author":"David","year":"2023","journal-title":"Cureus"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Giakoumaki, M., Lambrou, G.I., Vlachodimitropoulos, D., Tagka, A., Vitsos, A., Kyriazi, M., Dimakopoulou, A., Anagnostou, V., Karasmani, M., and Deli, H. (2024). Type I Diabetes Mellitus Suppresses Experimental Skin Carcinogenesis. Cancers, 16.","DOI":"10.3390\/cancers16081507"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4161\/derm.17027","article-title":"Thyroid Hormone Action on Skin","volume":"3","author":"Safer","year":"2011","journal-title":"Dermatoendocrinology"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Gratton, R., Del Vecchio, C., Zupin, L., and Crovella, S. (2022). Unraveling the Role of Sex Hormones on Keratinocyte Functions in Human Inflammatory Skin Diseases. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23063132"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Kim, H.J., and Kim, Y.H. (2024). Exploring Acne Treatments: From Pathophysiological Mechanisms to Emerging Therapies. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25105302"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Gruber, J.V., Stojkoska, V., and Riemer, J. (2020). Retinol Has a Skin Dehydrating Effect That Can Be Improved by a Mixture of Wa-Ter-Soluble Polysaccharides. Cosmetics, 7.","DOI":"10.3390\/cosmetics7040080"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Kowalska, J., and Wrze\u015bniok, D. (2024). Skin-Related Adverse Reactions Induced by Oral Antidiabetic Drugs\u2014A Review of Literature and Case Reports. Pharmaceuticals, 17.","DOI":"10.3390\/ph17070847"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000501732","article-title":"Skin Metabolism: Relevance of Skin Enzymes for Rational Drug Design","volume":"32","author":"Pyo","year":"2019","journal-title":"Ski. Pharmacol. Physiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.2174\/0115701808306902240604071741","article-title":"Enhanced Permeation Retention Effect-Modeling and Imaging Approaches for Nanoparticle-Mediated Anti-Cancer Diagnostics or Therapy","volume":"21","author":"Suresh","year":"2024","journal-title":"Lett. Drug Des. Discov."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Serzants, R., Svalbe, B., Cesnokova, I., Stelfa, G., and Sizovs, A. (2024). Exploring the Limits of EPR-Driven Tumor Accumulation with Non-Opsonizing Nanomaterials. bioRxiv.","DOI":"10.1101\/2024.05.07.592926"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.25258\/ijddt.14.4.29","article-title":"Formulation Challenges in Dermal Drug Delivery Systems: A Comprehensive Review of Physicochemical Properties and Advanced Delivery Strategies","volume":"14","author":"Vijaykumar","year":"2024","journal-title":"Int. J. Drug Deliv. Technol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Czyrski, G.S., Hjort, M.K.F., Rades, T., and Heinz, A. (2024). Comparing Effects of Terpene-Based Deep Eutectic Solvent and Solid Microneedles on Skin Permeation of Drugs with Varying Lipophilicity. Eur. J. Pharm. Biopharm., 205.","DOI":"10.1016\/j.ejpb.2024.114576"},{"key":"ref_69","first-page":"311","article-title":"Exploratory Data Analysis of the Dependencies between Skin Permeability, Molecular Weight and Log P","volume":"71","author":"Kilian","year":"2016","journal-title":"Die Pharm."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.1039\/D4CP03621B","article-title":"Expanded ensemble predictions of toluene\u2013water partition coefficients in the SAMPL9 log P challenge","volume":"27","author":"Goold","year":"2025","journal-title":"Phys. Chem. Chem. Phys."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Algotsson, J., J\u00f6nsson, P., Forsman, J., Topgaard, D., and S\u00f6derman, O. (2019). Intermolecular Interactions Play a Role in the Distribution and Transport of Charged Contrast Agents in a Cartilage Model. PLoS ONE, 14.","DOI":"10.1101\/591255"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1021\/acs.molpharmaceut.2c01078","article-title":"Computational Prodrug Design Methodology for Liposome Formulability Enhancement of Small-Molecule APIs","volume":"20","author":"Balouch","year":"2023","journal-title":"Mol. Pharm."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Gavhane, S.A., and Somwanshi, S.B. (2024). Prodrug: Approach to Better Drug Delivery, IIP.","DOI":"10.58532\/V3BIPN8P1CH8"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Sahu, S.K., Singh, A., Verma, P., and Chaurasiya, S. (2024). Prodrug: A Brief Concept, IIP.","DOI":"10.58532\/V3BIPN9CH22"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"34996","DOI":"10.1039\/D4RA06266C","article-title":"Enhancing Skin Delivery of Tranexamic Acid via Esterification: Synthesis and Evaluation of Alkyl Ester Derivatives","volume":"14","author":"Zeng","year":"2024","journal-title":"RSC Adv."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1055\/s-0041-1737911","article-title":"Synthesis of Phosphoramidate Prodrugs of Phenolic Natural Products and Drugs by Ester Exchange","volume":"54","author":"Wu","year":"2022","journal-title":"Synthesis"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.canlet.2005.11.029","article-title":"Skin Delivery Potency and Antitumor Activities of Temozolomide Ester Prodrugs","volume":"244","author":"Suppasansatorn","year":"2006","journal-title":"Cancer Lett."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"101644","DOI":"10.1016\/j.pdpdt.2019.101644","article-title":"Topical 5-Aminolevulinic Acid-Mediated Photodynamic Therapy for Basal Cell Carcinoma","volume":"30","author":"Filonenko","year":"2020","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"ref_79","first-page":"32","article-title":"Therapeutic and Aesthetic Uses of Photodynamic Therapy Part Five of a Five-Part Series: ALA-PDT in Clinical Practice How One Clinician Performs This Procedure","volume":"2","author":"Gold","year":"2009","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Champeau, M., Vignoud, S., Mortier, L., and Mordon, S. (2019). Photodynamic Therapy for Skin Cancer: How to Enhance Drug Penetration?. J. Photochem. Photobiol. B, 197.","DOI":"10.1016\/j.jphotobiol.2019.111544"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0939-6411(02)00006-1","article-title":"Comparative Permeation Studies for Delta-Aminolevulinic Acid and Its n-Butylester through Stratum Corneum and Artificial Skin Constructs","volume":"53","author":"Winkler","year":"2002","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/bjd.13924","article-title":"Hexyl-5-aminolaevulinate 0\u00b72% vs. Methyl-5-aminolaevulinate 16% Daylight Photodynamic Therapy for Treatment of Actinic Keratoses: Results of a Randomized Double-blinded Pilot Trial","volume":"174","author":"Karppinen","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2174\/157016306780136772","article-title":"Prodrug Strategy for Enhancing Drug Delivery via Skin","volume":"3","author":"Fang","year":"2006","journal-title":"Curr. Drug Discov. Technol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0378-5173(01)00892-4","article-title":"A Topological Study of Prodrugs of 5-Fluorouracil","volume":"231","author":"Quigley","year":"2002","journal-title":"Int. J. Pharm."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0378-5173(97)00108-7","article-title":"Effect of Vehicles on Topical Delivery of 5-Fluorouracil (5FU) by 1-Acyl-5FU Prodrugs","volume":"154","author":"Patrick","year":"1997","journal-title":"Int. J. Pharm."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Alberts, D., and Hess, L. (2005). Developing Topical Prodrugs for Skin Cancer Prevention. Fundamentals of Cancer Prevention, Springer.","DOI":"10.1007\/b137426"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1080\/02652048.2019.1677796","article-title":"Imiquimod-Oleic Acid Prodrug-Loaded Cream Reduced Drug Crystallinity and Induced Indistinguishable Cytotoxicity and Apoptosis in Mice Melanoma Tumour","volume":"36","author":"Sharma","year":"2019","journal-title":"J. Microencapsul."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1007\/s13555-023-00993-1","article-title":"Topical Treatment of Melanoma In Situ, Lentigo Maligna, and Lentigo Maligna Melanoma with Imiquimod Cream: A Systematic Review of the Literature","volume":"13","author":"Vaienti","year":"2023","journal-title":"Dermatol. Ther."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Lein, A., and Oussoren, C. (2015). Dermal. In Practical Pharmaceutics, Springer International Publishing Switzerland.","DOI":"10.1007\/978-3-319-15814-3_12"},{"key":"ref_90","first-page":"104","article-title":"A Brief Review of Vehicles for Topical Therapies","volume":"37","author":"Ahuja","year":"2025","journal-title":"Ski. Pharmacol. Physiol."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Herbig, M.E., Evers, D.-H., Gorissen, S., and K\u00f6llmer, M. (2023). Rational Design of Topical Semi-Solid Dosage Forms-How Far Are We?. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15071822"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Kim, S., Day, C., Song, Y., Holmes, A., and Garg, S. (2023). Innovative Topical Patches for Non-Melanoma Skin Cancer: Current Challenges and Key Formulation Considerations. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15112577"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2113269","DOI":"10.1002\/adfm.202113269","article-title":"Microneedle Patches Integrated with Biomineralized Melanin Nanoparticles for Simultaneous Skin Tumor Photothermal Therapy and Wound Healing","volume":"32","author":"Lei","year":"2022","journal-title":"Adv. Funct. Mater."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Dragicevic, N., Predic Atkinson, J., and Maibach, H.I. (2015). Chemical Penetration Enhancers: Classification and Mode of Action, Springer.","DOI":"10.1007\/978-3-662-47039-8_2"},{"key":"ref_95","first-page":"171","article-title":"Development Strategy of Dermal and Transdermal Formulation: Synergistic Effect of Chemical Penetration Enhancers","volume":"51","year":"2024","journal-title":"Acta Med. Bulg."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.22214\/ijraset.2024.62051","article-title":"A Review Article on Permeability Enhancement","volume":"12","author":"Borude","year":"2024","journal-title":"Int. J. Res. Appl. Sci. Eng. Technol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1155\/2008\/109782","article-title":"Penetration Mechanism of Dimethyl Sulfoxide in Human and Pig Ear Skin: An ATR-FTIR and near-FT Raman Spectroscopic in Vivo and in Vitro Study","volume":"22","author":"Greve","year":"2008","journal-title":"Spectroscopy"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Kulkarni, V.S., and Shaw, C. (2016). Use of Polymers and Thickeners in Semisolid and Liquid Formulations. Essential Chemistry for Formulators of Semisolid and Liquid Dosages, Academic Press.","DOI":"10.1016\/B978-0-12-801024-2.00005-4"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Jamp\u00edlek, J. (2015). Azone\u00ae and Its Analogues as Penetration Enhancers. Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement, Springer.","DOI":"10.1007\/978-3-662-47039-8_6"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.18311\/jnr\/2024\/45113","article-title":"Unlocking Skin Barriers: Applications and Properties of Natural Permeation Enhancers","volume":"24","author":"Singh","year":"2024","journal-title":"J. Nat. Remedies"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Hmingthansanga, V., Singh, N., Banerjee, S., Manickam, S., Velayutham, R., and Natesan, S. (2022). Improved Topical Drug Delivery: Role of Permeation Enhancers and Advanced Approaches. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14122818"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/0122117385331393241111073911","article-title":"Emerging Trends in Transdermal Drug Delivery: Nanoparticle Formulations and Technologies for Enhanced Skin Penetration and Drug Efficiency","volume":"13","author":"Dudhat","year":"2024","journal-title":"Pharm. Nanotechnol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.2174\/1381612826666200819202821","article-title":"A Comprehensive Review on Nanotechnology-Based Innovations in Topical Drug Delivery for the Treatment of Skin Cancer","volume":"26","author":"Lalotra","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.addr.2020.05.011","article-title":"Nanoparticles for Topical Drug Delivery: Potential for Skin Cancer Treatment","volume":"153","author":"Krishnan","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e09394","DOI":"10.1016\/j.heliyon.2022.e09394","article-title":"Liposomes: Structure, Composition, Types, and Clinical Applications","volume":"8","author":"Nsairat","year":"2022","journal-title":"Heliyon"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Sercombe, L., Veerati, T., Moheimani, F., Wu, S., Sood, A., and Hua, S. (2015). Advances and Challenges of Liposome Assisted Drug Delivery. Front. Pharmacol., 6.","DOI":"10.3389\/fphar.2015.00286"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jconrel.2023.02.006","article-title":"Skin Drug Delivery Using Lipid Vesicles: A Starting Guideline for Their Development","volume":"355","author":"Guillot","year":"2023","journal-title":"J. Control. Release"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Gugleva, V., Ivanova, N., Sotirova, Y., and Andonova, V. (2021). Dermal Drug Delivery of Phytochemicals with Phenolic Structure via Lipid-Based Nanotechnologies. Pharmaceuticals, 14.","DOI":"10.3390\/ph14090837"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3390\/chemistry6050058","article-title":"Ethosomes: A Promising Drug Delivery Platform for Transdermal Application","volume":"6","author":"Zhan","year":"2024","journal-title":"Chemistry"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Musielak, E., and Krajka-Ku\u017aniak, V. (2024). Liposomes and Ethosomes: Comparative Potential in Enhancing Skin Permeability for Therapeutic and Cosmetic Applications. Cosmetics, 11.","DOI":"10.3390\/cosmetics11060191"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Matharoo, N., Mohd, H., and Michniak-Kohn, B. (2024). Transferosomes as a Transdermal Drug Delivery System: Dermal Kinetics and Recent Developments. WIREs Nanomed. Nanobiotechnol., 16.","DOI":"10.1002\/wnan.1918"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"118817","DOI":"10.1016\/j.ijpharm.2019.118817","article-title":"Transferosomes as Nanocarriers for Drugs across the Skin: Quality by Design from Lab to Industrial Scale","volume":"573","author":"Lalatsa","year":"2020","journal-title":"Int. J. Pharm."},{"key":"ref_113","first-page":"23","article-title":"Niosomal Drug Delivery for Transdermal Targeting: Recent Advances","volume":"4","author":"Muzzalupo","year":"2015","journal-title":"Res. Rep. Transdermal Drug Deliv."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"124747","DOI":"10.1016\/j.ijpharm.2024.124747","article-title":"Quality by Design for Niosome-Based Nanocarriers to Improve Transdermal Drug Delivery from Lab to Industry","volume":"666","author":"Kaur","year":"2024","journal-title":"Int. J. Pharm."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Oliveira, C.A., Forster, C., Feitosa, V., Baby, A.R., L\u00e9o, P., and Rangel-Yagui, C.O. (2021). Catalase-Loaded Polymersomes as a Promising Safe Ingredient to Active Photoprotection. J. Photochem. Photobiol., 7.","DOI":"10.1016\/j.jpap.2021.100056"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Fonseca, M., Jarak, I., Victor, F., Domingues, C., Veiga, F., and Figueiras, A. (2024). Polymersomes as the Next Attractive Generation of Drug Delivery Systems: Definition, Synthesis and Applications. Materials, 17.","DOI":"10.3390\/ma17020319"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"218","DOI":"10.34172\/apb.2023.028","article-title":"Polymersomes Based Versatile Nanoplatforms for Controlled Drug Delivery and Imaging","volume":"13","author":"Kotha","year":"2023","journal-title":"Adv. Pharm. Bull."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.2147\/IJN.S444910","article-title":"Polymersomes for Therapeutic Protein and Peptide Delivery: Towards Better Loading Properties","volume":"19","author":"Hua","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"102166","DOI":"10.1016\/j.jddst.2020.102166","article-title":"Invasomes: Potential Vesicular Systems for Transdermal Delivery of Drug Molecules","volume":"61","author":"Jain","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/0124681873327435241004053618","article-title":"Invasomes: An Artificial Vesicle Nanocarrier to Enhance Transdermal Drug Delivery","volume":"15","author":"Preeti","year":"2024","journal-title":"Curr. Nanomed."},{"key":"ref_121","first-page":"287","article-title":"Pharmacosomes and Emulsomes: An Emerging Novel Vesicular Drug Delivery System","volume":"3","author":"Afreen","year":"2020","journal-title":"Glob. J. Anesthesia Pain Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/2468187311666210521100441","article-title":"Pharmacosomes: A Versatile Delivery System for Problematic Molecules","volume":"11","author":"Rana","year":"2021","journal-title":"Curr. Nanomed."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"e16561","DOI":"10.1016\/j.heliyon.2023.e16561","article-title":"Overview of Phytosomes in Treating Cancer: Advancement, Challenges, and Future Outlook","volume":"9","author":"Gaikwad","year":"2023","journal-title":"Heliyon"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"6983","DOI":"10.2147\/IJN.S318416","article-title":"Phytosomes as Innovative Delivery Systems for Phytochemicals: A Comprehensive Review of Literature","volume":"16","author":"Barani","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2683466","DOI":"10.1155\/2024\/2683466","article-title":"Recent Advances in the Use of Cubosomes as Drug Carriers with Special Emphasis on Topical Applications","volume":"2024","author":"Nath","year":"2024","journal-title":"J. Lipids"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Nayak, A.K., Hasnain, M.S., Aminabhavi, T.M., and Torchilin, V.P. (2022). Chapter 9\u2014Cubosomes: A Promising Vesicular System for Drug Delivery. Systems of Nanovesicular Drug Delivery, Academic Press.","DOI":"10.1016\/B978-0-323-91864-0.00026-7"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Nayak, A.K., Hasnain, M.S., Aminabhavi, T.M., and Torchilin, V.P. (2022). Chapter 17\u2014Glycerosomes: A New Tool for Effective Drug Delivery. Systems of Nanovesicular Drug Delivery, Academic Press.","DOI":"10.1016\/B978-0-323-91864-0.00026-7"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijpharm.2013.07.060","article-title":"Glycerosomes: A New Tool for Effective Dermal and Transdermal Drug Delivery","volume":"455","author":"Manca","year":"2013","journal-title":"Int. J. Pharm."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1039\/D0RA08305D","article-title":"Chitosan-Covered Liposomes as a Promising Drug Transporter: Nanoscale Investigations","volume":"11","author":"Mohammed","year":"2021","journal-title":"RSC Adv."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Gaynanova, G., Vasileva, L., Kashapov, R., Kuznetsova, D., Kushnazarova, R., Tyryshkina, A., Vasilieva, E., Petrov, K., Zakharova, L., and Sinyashin, O. (2021). Self-Assembling Drug Formulations with Tunable Permeability and Biodegradability. Molecules, 26.","DOI":"10.3390\/molecules26226786"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Sebaaly, C., Trifan, A., Sieniawska, E., and Greige-Gerges, H. (2021). Chitosan-Coating Effect on the Characteristics of Liposomes: A Focus on Bioactive Compounds and Essential Oils: A Review. Processes, 9.","DOI":"10.3390\/pr9030445"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"103094","DOI":"10.1016\/j.jddst.2022.103094","article-title":"A Comparative Study of Liposomes and Chitosomes for Topical Quercetin Antioxidant Therapy","volume":"68","author":"Colino","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.tifs.2020.12.003","article-title":"Liposomes vs. Chitosomes: Encapsulating Food Bioactives","volume":"108","author":"Esposto","year":"2021","journal-title":"Trends Food Sci. Technol."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Viegas, C., Patr\u00edcio, A., Prata, J., Nadhman, A., Chintamaneni, P., and Fonte, P. (2023). Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15061593"},{"key":"ref_135","first-page":"24","article-title":"Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Current Perspectives in Wound Care","volume":"10","author":"Sotirova","year":"2023","journal-title":"Scr. Sci. Pharm."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"104709","DOI":"10.1016\/j.jddst.2023.104709","article-title":"Solid Lipid Nanoparticles: An Effective Lipid-Based Technology for Cancer Treatment","volume":"86","author":"Akanda","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Mall, J., Naseem, N., Haider, M.F., Rahman, M.A., Khan, S., and Siddiqui, S.N. (2024). Nanostructured Lipid Carriers as a Drug Delivery System: A Comprehensive Review with Therapeutic Applications. Intell. Pharm.","DOI":"10.1016\/j.ipha.2024.09.005"},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Souto, E.B., Cano, A., Martins-Gomes, C., Coutinho, T.E., Zieli\u0144ska, A., and Silva, A.M. (2022). Microemulsions and Nanoemulsions in Skin Drug Delivery. Bioengineering, 9.","DOI":"10.3390\/bioengineering9040158"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1208\/s12249-024-02997-2","article-title":"Understanding Microemulsions and Nanoemulsions in (Trans)Dermal Delivery","volume":"26","author":"Musakhanian","year":"2025","journal-title":"AAPS PharmSciTech"},{"key":"ref_140","unstructured":"Mohd Setapar, S.H., Ahmad, A., and Jawaid, M. (2022). Chapter 14\u2014In Vitro and in Vivo Safety Evaluation of Nanoemulsion as Skin Moisturizer. Nanotechnology for the Preparation of Cosmetics Using Plant-Based Extracts, Elsevier."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"458","DOI":"10.2174\/1567201813666160824125444","article-title":"Traversing the Skin Barrier with Nano-Emulsions","volume":"14","author":"Burger","year":"2017","journal-title":"Curr. Drug Deliv."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/pharmaceutics6010052","article-title":"Overcoming the Cutaneous Barrier with Microemulsions","volume":"6","author":"Lopes","year":"2014","journal-title":"Pharmaceutics"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1134\/S1061933X12060026","article-title":"Hydrogels Based on Polycarboxylic Acid-Agar-Agar Complexes","volume":"74","author":"Baranovskii","year":"2012","journal-title":"Colloid. J."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"e20802","DOI":"10.1590\/s2175-97902022e20802","article-title":"Applications of Polysaccharides in Topical and Transdermal Drug Delivery: A Recent Update of Literature","volume":"58","author":"Parhi","year":"2022","journal-title":"Braz. J. Pharm. Sci."},{"key":"ref_145","first-page":"49","article-title":"Preparation and Characterization of Polyethylene Oxide Hydrogels with Cytisine","volume":"46","author":"Dimitrov","year":"2004","journal-title":"Acta Pharm. Turc."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Singpanna, K., Pornpitchanarong, C., and Patrojanasophon, P. (2024). Nanocomposite Patches for Transdermal Drug Delivery: A Review. Sci. Eng. Health Stud., 24010005.","DOI":"10.69598\/sehs.18.24010005"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"121290","DOI":"10.1016\/j.ijpharm.2021.121290","article-title":"The Technology of Transdermal Delivery Nanosystems: From Design and Development to Preclinical Studies","volume":"611","author":"Despotopoulou","year":"2022","journal-title":"Int. J. Pharm."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"34","DOI":"10.22159\/ijap.2018v10i5.27075","article-title":"Recent Progress of Dendrimers in Drug Delivery for Cancer Therapy","volume":"10","author":"Anitha","year":"2018","journal-title":"Int. J. Appl. Pharm."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1007\/s10904-021-01925-2","article-title":"Applications of Dendrimers in Nanomedicine and Drug Delivery: A Review","volume":"31","author":"Nikzamir","year":"2021","journal-title":"J. Inorg. Organomet. Polym. Mater."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Pandita, D., Madaan, K., Kumar, S., Poonia, N., and Lather, V. (2014). Dendrimers in Drug Delivery and Targeting: Drug-Dendrimer Interactions and Toxicity Issues. J. Pharm. Bioallied Sci., 6.","DOI":"10.4103\/0975-7406.130965"},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Rout, S., Bandaru, R., Kenguva, G., Hasan, N., Alam, M.S., Shukla, R., Almalki, H., Kesharwani, P., and Dandela, R. (2023). Dendrimers in Photodynamic Therapy. Nanomater. Photodyn. Ther., 281\u2013305.","DOI":"10.1016\/B978-0-323-85595-2.00004-9"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejpb.2020.12.014","article-title":"Dendrimer-Mediated Permeation Enhancement of Chlorhexidine Digluconate: Determination of in Vitro Skin Permeability and Visualisation of Dermal Distribution","volume":"159","author":"Kirkby","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Kokaz, S.F., Deb, P.K., Borah, P., Bania, R., Venugopala, K.N., Nair, A.B., Singh, V., Al-Shar\u2019i, N.A., Hourani, W., and Gupta, G. (2021). Dendrimers: Properties and Applications in Biomedical Field. Nanoeng. Biomater., 215\u2013243.","DOI":"10.1002\/9783527832095.ch25"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Sorroza-Mart\u00ednez, K., Ruiu, A., Gonz\u00e1lez-M\u00e9ndez, I., and Rivera, E. (2021). Design and Properties of Dendrimers for Pharmaceutical Applications. Dendrimer-Based Nanother., 15\u201331.","DOI":"10.1016\/B978-0-12-821250-9.00002-0"},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Dangova, M., Ivanova, N., and Andonova, V. (2025). Nanocarriers-Assisted Nose-to-Brain Delivery of Levodopa: Current Progress and Prospects. Appl. Sci., 15.","DOI":"10.3390\/app15010331"},{"key":"ref_156","first-page":"14071","article-title":"Inorganic Nanomaterials for Bioimaging, Targeted Drug Delivery and Therapeutics","volume":"46","author":"Liang","year":"2015","journal-title":"ChemInform"},{"key":"ref_157","first-page":"395","article-title":"Inorganic Nanomaterials; A Brief Overview of the Applications and Developments in Sensing and Drug Delivery","volume":"3","author":"Nasirzadeh","year":"2016","journal-title":"J. Appl. Biotechnol. Rep."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nmat3776","article-title":"Stimuli-Responsive Nanocarriers for Drug Delivery","volume":"12","author":"Mura","year":"2013","journal-title":"Nat. Mater."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Pham, S.H., Choi, Y., and Choi, J. (2020). Stimuli-Responsive Nanomaterials for Application in Antitumor Therapy and Drug Delivery. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12070630"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s42247-022-00426-3","article-title":"Biosafety of Inorganic Nanomaterials for Theranostic Applications","volume":"5","author":"Kang","year":"2022","journal-title":"Emerg. Mater."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"38","DOI":"10.59400\/nmm.v3i1.38","article-title":"Nanomaterials in Drug Delivery\u2014Promises and Limitations","volume":"3","author":"Mishra","year":"2023","journal-title":"Nano Med Mater."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"100190","DOI":"10.1016\/j.onano.2023.100190","article-title":"Nanotoxicity Induced by Nanomaterials: A Review of Factors Affecting Nanotoxicity and Possible Adaptations","volume":"14","author":"Thu","year":"2023","journal-title":"OpenNano"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"7873","DOI":"10.1166\/jnn.2016.13032","article-title":"Toxicity of Inorganic Nanoparticles Used in Targeted Drug Delivery and Other Biomedical Application: An Updated Account on Concern of Biomedical Nanotoxicology","volume":"16","author":"Ahmad","year":"2016","journal-title":"J. Nanosci. Nanotechnol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"104806","DOI":"10.1016\/j.jddst.2023.104806","article-title":"Challenges and Toxicity Assessment of Inorganic Nanomaterials in Biomedical Applications: Current Status and Future Roadmaps","volume":"87","author":"Dhanavade","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"100872","DOI":"10.1016\/j.coche.2022.100872","article-title":"Inorganic Nanoparticle Engineering against Bacterial Infections","volume":"38","author":"Tsikourkitoudi","year":"2022","journal-title":"Curr. Opin. Chem. Eng."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1039\/D2CS00352J","article-title":"Bioactive Inorganic Nanomaterials for Cancer Theranostics","volume":"52","author":"Pei","year":"2023","journal-title":"Chem. Soc. Rev."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Pacyga, K., Pacyga, P., Szuba, E., Viscardi, S., Topola, E., and Duda-Madej, A. (2025). Nanotechnology Meets Phytotherapy: A Cutting-Edge Approach to Treat Bacterial Infections. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26031254"},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Ivanova, N., Ermenlieva, N., Simeonova, L., Kolev, I., Slavov, I., Karashanova, D., and Andonova, V. (2023). Chlorhexidine\u2013Silver Nanoparticle Conjugation Leading to Antimicrobial Synergism but Enhanced Cytotoxicity. Pharmaceutics, 15.","DOI":"10.20944\/preprints202308.1493.v1"},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Khan, S.S., Ullah, I., Ullah, S., An, R., Xu, H., Nie, K., Liu, C., and Liu, L. (2021). Recent Advances in the Surface Functionalization of Nanomaterials for Antimicrobial Applications. Materials, 14.","DOI":"10.3390\/ma14226932"},{"key":"ref_170","first-page":"1","article-title":"Functionalization of Nanomaterials: Synthesis and Characterization. Functionalized Nanomaterials for Corrosion Mitigation: Synthesis, Characterization, and Applications","volume":"1418","author":"Rizvi","year":"2022","journal-title":"Am. Chem. Soc."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3390\/applnano5040014","article-title":"Use of Metallic Nanoparticles Synthesized from Plant Extracts in Wound Healing\u2014A Review","volume":"5","year":"2024","journal-title":"Appl. Nano"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"51729","DOI":"10.1039\/C7RA08483H","article-title":"In Vitro Antimicrobial and in Vivo Wound Healing Effect of Actinobacterially Synthesised Nanoparticles of Silver, Gold and Their Alloy","volume":"7","author":"Shanmugasundaram","year":"2017","journal-title":"RSC Adv."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Jangid, H., Singh, S., Kashyap, P.K., and Singh, A. (2024). Advancing Biomedical Applications: An in-Depth Analysis of Silver Nanoparticles in Antimicrobial, Anticancer, and Wound Healing Roles. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1438227"},{"key":"ref_174","unstructured":"Soloneski, S., and Larramendy, M.L. (2015). In Vivo Assessment of Nanomaterials Toxicity. Nanomaterials, IntechOpen."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1080\/07391102.2020.1858965","article-title":"Photodynamic Cancer Therapy: Role of Ag- and Au-Based Hybrid Nano-Photosensitizers","volume":"40","author":"Dhanalekshmi","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"101692","DOI":"10.1016\/j.mtcomm.2020.101692","article-title":"Cellular Uptake and Retention of Nanoparticles: Insights on Particle Properties and Interaction with Cellular Components","volume":"25","author":"Augustine","year":"2020","journal-title":"Mater. Today Commun."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"237","DOI":"10.54254\/2755-2721\/24\/20230715","article-title":"The Comparison of Titanium Dioxide and Zinc Oxide Used in Sunscreen Based on Their Enhanced Absorption","volume":"24","author":"Wang","year":"2023","journal-title":"Appl. Comput. Eng."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"210","DOI":"10.54254\/2755-2721\/24\/20230710","article-title":"The Application of Metal Oxide Nanoparticles in Sunscreen and Their Potential Risks","volume":"24","author":"Wu","year":"2023","journal-title":"Appl. Comput. Eng."},{"key":"ref_179","first-page":"223","article-title":"Titanium Dioxide and Zinc Oxide Nanoparticles in Sunscreens: A Review of Toxicological Data","volume":"70","author":"Vujovic","year":"2019","journal-title":"J. Cosmet. Sci."},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Popov, A., Zhao, X., Zvyagin, A., Lademann, J., Roberts, M., Sanchez, W., Priezzhev, A., and Myllyl\u00e4, R. (2010). ZnO and TiO2 Particles: A Study on Nanosafety and Photoprotection. Biophotonics Photonic Solut. Better Health Care II, 7715.","DOI":"10.1117\/12.854561"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/17435390903502028","article-title":"Zinc Oxide Nanoparticles in Modern Sunscreens: An Analysis of Potential Exposure and Hazard","volume":"4","author":"Osmond","year":"2010","journal-title":"Nanotoxicology"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1007\/s00204-015-1564-z","article-title":"A Review of Critical Factors for Assessing the Dermal Absorption of Metal Oxide Nanoparticles from Sunscreens Applied to Humans, and a Research Strategy to Address Current Deficiencies","volume":"89","author":"Gulson","year":"2015","journal-title":"Arch. Toxicol."},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Warheit, D.B. (2024). Safety of titanium dioxide (E171) as a food additive for humans. Front. Toxicol., 19.","DOI":"10.3389\/ftox.2024.1333746"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0190-9622(81)80196-X","article-title":"Topical Chemotherapy with 5-Fluorouracil: A Review","volume":"4","author":"Goette","year":"1981","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2230.1982.tb02389.x","article-title":"Topical Cytostatic Drugs in the Treatment of Skin Cancer","volume":"7","year":"1982","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Kim, S., Woo, Y.R., Cho, S.H., Lee, J.D., and Kim, H.S. (2024). Clinical Efficacy of 5-Fluorouracil and Bleomycin in Dermatology. J. Clin. Med., 13.","DOI":"10.3390\/jcm13020335"},{"key":"ref_187","unstructured":"(2025, April 04). Available online: https:\/\/www.drugs.com\/monograph\/fluorouracil-topical.html."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/120347540300700201","article-title":"Topical treatment of Bowen\u2019s disease with 5-Fluorouracil","volume":"7","author":"Bargman","year":"2003","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1365-2133.2003.05033.x","article-title":"Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen\u2019s disease","volume":"148","author":"Salim","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jso.2930380409","article-title":"A Role for Topical 5-Fluorouracil Therapy in Melanoma","volume":"38","author":"Ryan","year":"1988","journal-title":"J. Surg. Oncol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jaad.2015.09.040","article-title":"Intralesional 5-fluorouracil (FU) as a treatment for nonmelanoma skin cancer (NMSC): A review","volume":"74","author":"Metterle","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.jaad.2020.12.049","article-title":"Intralesional 5-fluorouracil for the treatment of squamous cell carcinomas","volume":"84","author":"Maxfield","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/ajd.14148","article-title":"Intralesional 5-fluorouracil as a management for cutaneous squamous cell carcinomas: A rural Australian retrospective case series","volume":"64","author":"Luu","year":"2023","journal-title":"Australas J. Dermatol."},{"key":"ref_194","first-page":"1150","article-title":"Treatment of squamous cell carcinoma with intralesional 5-Fluorouracil","volume":"29","author":"Morse","year":"2003","journal-title":"Dermatol. Surg."},{"key":"ref_195","first-page":"454","article-title":"Treatment of giant keratoacanthoma with intralesional 5-fluorouracil","volume":"5","author":"Leonard","year":"2006","journal-title":"J. Drugs Dermatol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1166\/mex.2022.2151","article-title":"Mechanism of 5-Fluorouracil Nanoparticles on Releasing Skin Squamous Cell Carcinoma through Regulation of Wnt\/\u03b2-Catenin Expression","volume":"12","author":"Peng","year":"2022","journal-title":"Mater. Express"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"e106065","DOI":"10.15252\/embj.2020106065","article-title":"5-Fluorouracil Efficacy Requires Anti-Tumor Immunity Triggered by Cancer-Cell-Intrinsic STING","volume":"40","author":"Tian","year":"2021","journal-title":"EMBO J."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.1039\/C9CE00661C","article-title":"Intermolecular Interactions and Permeability of 5-Fluorouracil Cocrystals with a Series of Isomeric Hydroxybenzoic Acids: A Combined Theoretical and Experimental Study","volume":"21","author":"Dai","year":"2019","journal-title":"CrystEngComm"},{"key":"ref_199","doi-asserted-by":"crossref","unstructured":"Nikam, A.N., Jacob, A., Raychaudhuri, R., Fernandes, G., Pandey, A., Rao, V., Ahmad, S.F., Pannala, A.S., and Mutalik, S. (2023). Topical Micro-Emulsion of 5-Fluorouracil by a Twin Screw Processor-Based Novel Continuous Manufacturing Process for the Treatment of Skin Cancer: Preparation and In Vitro and In Vivo Evaluations. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15092175"},{"key":"ref_200","unstructured":"(2025, April 04). Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=5-fluorouracil+skin+cancer&filter=datesearch.y_1."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.4314\/tjpr.v15i11.3","article-title":"Topical Nano-Delivery of 5-Fluorouracil: Preparation and Characterization of Water-in-Oil Nanoemulsion","volume":"15","author":"Siddalingam","year":"2016","journal-title":"Trop. J. Pharm. Res."},{"key":"ref_202","doi-asserted-by":"crossref","unstructured":"Nawaz, A., Latif, M.S., Alnuwaiser, M.A., Ullah, S., Iqbal, M., Alfatama, M., and Lim, V. (2022). Synthesis and Characterization of Chitosan-Decorated Nanoemulsion Gel of 5-Fluorouracil for Topical Delivery. Gels, 8.","DOI":"10.3390\/gels8070412"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1208\/s12249-022-02356-z","article-title":"Sorbitan Monolaurate\u2013Containing Liposomes Enhance Skin Cancer Cell Cytotoxicity and in Association with Microneedling Increase the Skin Penetration of 5-Fluorouracil","volume":"23","author":"Carvalho","year":"2022","journal-title":"AAPS Pharmscitech"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"020024","DOI":"10.1063\/1.5047778","article-title":"5-Fluorouracil-Loaded Ultradeformable Liposomes for Skin Therapy","volume":"1990","author":"Calienni","year":"2018","journal-title":"AIP Conf. Proc."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2015.04.056","article-title":"Ultradeformable Liposomes as Multidrug Carrier of Resveratrol and 5-Fluorouracil for Their Topical Delivery","volume":"489","author":"Cosco","year":"2015","journal-title":"Int. J. Pharm."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jconrel.2018.05.038","article-title":"Skin Cancer Treatment Effectiveness Is Improved by Iontophoresis of EGFR-Targeted Liposomes Containing 5-FU Compared with Subcutaneous Injection","volume":"283","author":"Petrilli","year":"2018","journal-title":"J. Control. Release"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1080\/10837450.2020.1803910","article-title":"Surface Modified Nanoliposome Formulations Provide Sustained Release for 5-FU and Increase Cytotoxicity on A431 Cell Line","volume":"25","author":"Yaman","year":"2020","journal-title":"Pharm. Dev. Technol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"45405","DOI":"10.1021\/acsomega.3c04457","article-title":"5-Fluorouracil-Loaded Hyaluronic Acid-Coated Niosomal Vesicles: Fabrication and Ex Vivo Evaluation for Skin Drug Delivery","volume":"8","author":"Khalid","year":"2023","journal-title":"ACS Omega"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1080\/21691401.2018.1431650","article-title":"5-Fluorouracil Ethosomes-Skin Deposition and Melanoma Permeation Synergism with Microwave","volume":"46","author":"Khan","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/CAD.0b013e3283534051","article-title":"Ethogel Topical Formulation for Increasing the Local Bioavailability of 5-Fluorouracil: A Mechanistic Study","volume":"23","author":"Puri","year":"2012","journal-title":"Anti-Cancer Drugs"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"116454","DOI":"10.1016\/j.envres.2023.116454","article-title":"Advanced Multifunctional Nano-Lipid Carrier Loaded Gel for Targeted Delivery of 5-Flurouracil and Cannabidiol against Non-Melanoma Skin Cancer","volume":"233","author":"Hasan","year":"2023","journal-title":"Environ. Res."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.2147\/IJN.S117511","article-title":"Development and Evaluation of Nanostructured Lipid Carrier-Based Hydrogel for Topical Delivery of 5-Fluorouracil","volume":"11","author":"Rajinikanth","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"ref_213","doi-asserted-by":"crossref","unstructured":"Ali, A., Madni, A., Shah, H.A., Jamshaid, T., Jan, N., Khan, S., Khan, M.M., and Mahmood, M.A. (2023). Solid Lipid-Based Nanoparticulate System for Sustained Release and Enhanced in-Vitro Cytotoxic Effect of 5-Fluorouracil on Skin Melanoma and Squamous Cell Carcinoma. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0281004"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1080\/10717544.2016.1194498","article-title":"5-Fluorouracil Shell-Enriched Solid Lipid Nanoparticles (SLN) for Effective Skin Carcinoma Treatment","volume":"23","author":"Khallaf","year":"2016","journal-title":"Drug Deliv."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/2228-5326-3-36","article-title":"In Vitro Anticancer Evaluation of 5-Fluorouracil Lipid Nanoparticles Using B16F10 Melanoma Cell Lines","volume":"3","author":"Shenoy","year":"2013","journal-title":"Int. Nano Lett."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2174\/1872210513666190702165556","article-title":"Study of 5-Fluorouracil Loaded Chitosan Nanoparticles for Treatment of Skin Cancer","volume":"14","author":"Patel","year":"2020","journal-title":"Recent Pat. Nanotechnol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2174\/1872210513666190314095643","article-title":"Formulation, Characterization and In Vitro Cytotoxicity of 5-Fluorouracil Loaded Polymeric Electrospun Nanofibers for the Treatment of Skin Cancer","volume":"13","author":"Patel","year":"2019","journal-title":"Recent Pat. Nanotechnol."},{"key":"ref_218","doi-asserted-by":"crossref","unstructured":"Skok, K., Zidari\u010d, T., Orthaber, K., Pristovnik, M., Kostev\u0161ek, N., \u017du\u017eek Ro\u017eman, K., \u0160turm, S., Gradi\u0161nik, L., Maver, U., and Maver, T. (2022). Novel Methacrylate-Based Multilayer Nanofilms with Incorporated FePt-Based Nanoparticles and the Anticancer Drug 5-Fluorouracil for Skin Cancer Treatment. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14040689"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1021\/acs.molpharmaceut.8b00047","article-title":"Fluorouracil-Loaded Gold Nanoparticles for the Treatment of Skin Cancer: Development, in Vitro Characterization, and in Vivo Evaluation in a Mouse Skin Cancer Xenograft Model","volume":"15","author":"Safwat","year":"2018","journal-title":"Mol. Pharm."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijbiomac.2022.02.096","article-title":"Controlled Release of 5-Fluorouracil to Melanoma Cells Using a Hydrogel\/Micelle Composites Based on Deoxycholic Acid and Carboxymethyl Chitosan","volume":"206","author":"Pourmanouchehri","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_221","doi-asserted-by":"crossref","unstructured":"Mohammad, O., Faisal, S.M., and Ahmad, N. (2019). Bio-Mediated Synthesis of 5-FU Based Nanoparticles Employing Orange Fruit Juice: A Novel Drug Delivery System to Treat Skin Fibrosarcoma in Model Animals. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-48180-7"},{"key":"ref_222","doi-asserted-by":"crossref","unstructured":"Shojaei, S., Doostan, M., Mohammadi Motlagh, H., Esnaashari, S., and Maleki, H. (2024). Development of 5-Fluorouracil\/Etoposide Co-Loaded Electrospun Nanofibrous Scaffold for Localized Anti-Melanoma Therapy. J. Appl. Biomater. Funct. Mater., 22.","DOI":"10.1177\/22808000241284439"},{"key":"ref_223","unstructured":"Nanda, J., and Bermudez, R. (2025). Imiquimod. StatPearls, StatPearls Publishing."},{"key":"ref_224","doi-asserted-by":"crossref","unstructured":"Garcia-Mouronte, E., Bern\u00e1-Rico, E., de Nicolas-Ruanes, B., Azcarraga-Llobet, C., and Bea-Ardebol, S. (2023). Imiquimod as Local Immunotherapy in the Management of Premalignant Cutaneous Conditions and Skin Cancer. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241310835"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1038\/onc.2013.343","article-title":"Imiquimod Directly Inhibits Hedgehog Signalling by Stimulating Adenosine Receptor\/Protein Kinase A-Mediated GLI Phosphorylation","volume":"32","author":"Wolff","year":"2013","journal-title":"Oncogene"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1365-2230.2004.01601.x","article-title":"Open Study of the Efficacy and Mechanism of Action of Topical Imiquimod in Basal Cell Carcinoma","volume":"29","author":"Vidal","year":"2004","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/mc.21901","article-title":"Imiquimod Attenuates the Growth of UVB-Induced SCC in Mice through Th1\/Th17 Cells","volume":"52","author":"Yokogawa","year":"2013","journal-title":"Mol. Carcinog."},{"key":"ref_228","first-page":"443","article-title":"Melanoma in Situ Treated with Topical Imiquimod for Management of Persistently Positive Margins: A Review of Treatment Methods","volume":"15","author":"Fan","year":"2015","journal-title":"Ochsner J."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-4632.2005.02582.x","article-title":"Successful Treatment of Malignant Melanoma in Situ with Topical 5% Imiquimod Cream","volume":"44","author":"Ray","year":"2005","journal-title":"Int. J. Dermatol."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jaad.2006.01.055","article-title":"Imiquimod 5% Cream Monotherapy for Cutaneous Squamous Cell Carcinoma in Situ (Bowen\u2019s Disease): A Randomized, Double-Blind, Placebo-Controlled Trial","volume":"54","author":"Patel","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_231","doi-asserted-by":"crossref","unstructured":"Casadei, B.R., Lotierzo, M.C.G., Malheiros, B., and Barbosa, L.R.S. (2021). Drug Repurposing and Nanoparticles: New Strategies against Leishmaniasis. Applications of Nanobiotechnology for Neglected Tropical Diseases, Academic Press.","DOI":"10.1016\/B978-0-12-821100-7.00007-8"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2147\/CCID.S14109","article-title":"Safety, Efficacy, and Patient Acceptability of Imiquimod for Topical Treatment of Actinic Keratoses","volume":"4","author":"Berman","year":"2011","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_233","doi-asserted-by":"crossref","unstructured":"Sorgi, D., Sartori, A., Germani, S., Gentile, R.N., Bianchera, A., and Bettini, R. (2024). Imiquimod Solubility in Different Solvents: An Interpretative Approach. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16020282"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2147\/IJN.S400610","article-title":"Development and Optimization of Imiquimod-Loaded Nanostructured Lipid Carriers Using a Hybrid Design of Experiments Approach","volume":"18","author":"Kim","year":"2023","journal-title":"Int. J. Nanomed."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"196","DOI":"10.32947\/ajps.v19i4.650","article-title":"The Complementary Role of ToF-SIMS in the Assessment of Imiquimod Permeated into the Skin from a Microemulsion Dosage Form","volume":"19","author":"Marlow","year":"2019","journal-title":"Al Mustansiriyah J. Pharm. Sci."},{"key":"ref_236","doi-asserted-by":"crossref","unstructured":"Ghezzi, M., Pescina, S., Delledonne, A., Ferraboschi, I., Sissa, C., Terenziani, F., Remiro, P.D.F.R., Santi, P., and Nicoli, S. (2021). Improvement of Imiquimod Solubilization and Skin Retention via TPGS Micelles: Exploiting the Co-Solubilizing Effect of Oleic Acid. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13091476"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/bmc.1075","article-title":"Development and Validation of HPLC Method for Imiquimod Determination in Skin Penetration Studies","volume":"22","author":"Martins","year":"2008","journal-title":"Biomed. Chromatogr."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1208\/s12249-018-1288-5","article-title":"Design, Development, and Characterization of Imiquimod-Loaded Chitosan Films for Topical Delivery","volume":"20","author":"Layek","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"ref_239","doi-asserted-by":"crossref","unstructured":"Panoutsopoulou, E., Zbytovsk\u00e1, J., V\u00e1vrov\u00e1, K., and Paraskevopoulos, G. (2022). Phospholipid-Based Microemulsions for Cutaneous Imiquimod Delivery. Pharmaceuticals, 15.","DOI":"10.3390\/ph15050515"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1021\/acs.molpharmaceut.7b00348","article-title":"Gel-like TPGS-Based Microemulsions for Imiquimod Dermal Delivery: Role of Mesostructure on the Uptake and Distribution into the Skin","volume":"14","author":"Frattini","year":"2017","journal-title":"Mol. Pharm."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s43094-023-00568-z","article-title":"Nanoemulsion Drug Delivery System Loaded with Imiquimod: A QbD-Based Strategy for Augmenting Anti-Cancer Effects","volume":"9","author":"Jadhav","year":"2023","journal-title":"Future J. Pharm. Sci."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"123577","DOI":"10.1016\/j.ijpharm.2023.123577","article-title":"Nanoformulations for Dermal Delivery of Imiquimod: The Race of \u201cSoft\u201d against \u201cHard\u201d","volume":"648","author":"Balouch","year":"2023","journal-title":"Int. J. Pharm."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1080\/03639045.2022.2153861","article-title":"In Vitro Anti-Melanoma Activity of Imiquimod in Ultradeformable Nanovesicles","volume":"48","author":"Caimi","year":"2022","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_244","doi-asserted-by":"crossref","unstructured":"Tampucci, S., Guazzelli, L., Burgalassi, S., Carpi, S., Carpi, S., Chetoni, P., Mezzetta, A., Nieri, P., Polini, B., and Pomelli, C.S. (2020). pH-Responsive Nanostructures Based on Surface Active Fatty Acid-Protic Ionic Liquids for Imiquimod Delivery in Skin Cancer Topical Therapy. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12111078"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s10856-015-5524-1","article-title":"Development of Nanovesicular Systems for Dermal Imiquimod Delivery: Physicochemical Characterization and in Vitro\/in Vivo Evaluation","volume":"26","author":"Ma","year":"2015","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"ref_246","doi-asserted-by":"crossref","unstructured":"Carre\u00f1o, G.F., Alvarez-Figueroa, M.J., and Gonz\u00e1lez-Aramundiz, J.V. (2022). Dextran Nanocapsules with \u03c9-3 in Their Nucleus: An Innovative Nanosystem for Imiquimod Transdermal Delivery. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14112445"},{"key":"ref_247","doi-asserted-by":"crossref","unstructured":"Argenziano, M., Haimhoffer, \u00c1., Bastiancich, C., Jicsinszky, L., Caldera, F., Trotta, F., Scutera, S., Alotto, D., Fumagalli, M., and Musso, T. (2019). In Vitro Enhanced Skin Permeation and Retention of Imiquimod Loaded in \u03b2-Cyclodextrin Nanosponge Hydrogel. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11030138"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11095-020-02925-6","article-title":"Design of Chitosan Nanocapsules with Compritol 888 ATO\u00ae for Imiquimod Transdermal Administration. Evaluation of Their Skin Absorption by Raman Microscopy","volume":"37","year":"2020","journal-title":"Pharm. Res."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1177\/10600280211031329","article-title":"1% Tirbanibulin Ointment for the Treatment of Actinic Keratoses","volume":"56","author":"Dao","year":"2021","journal-title":"Ann. Pharmacother."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.2147\/CCID.S374122","article-title":"Tirbanibulin for Actinic Keratosis: Insights into the Mechanism of Action","volume":"15","author":"Schlesinger","year":"2022","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"55328","DOI":"10.12775\/JEHS.2024.70.55328","article-title":"Tirbanibulin as a Novel Treatment in Actinic Keratosis: A Literature Review","volume":"70","author":"Sajkiewicz","year":"2024","journal-title":"J. Educ. Health Sport."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s40122-018-0100-2","article-title":"A Review of Chronic Musculoskeletal Pain: Central and Peripheral Effects of Diclofenac","volume":"7","author":"Atzeni","year":"2018","journal-title":"Pain Ther."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10555-011-9306-z","article-title":"Cyclooxygenase-Dependent Signaling Is Causally Linked to Non-Melanoma Skin Carcinogenesis: Pharmacological, Genetic, and Clinical Evidence","volume":"30","year":"2011","journal-title":"Cancer Metastasis Rev."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2165\/00128071-200708040-00002","article-title":"The Role of Topical Cyclo-Oxygenase-2 Inhibitors in Skin Cancer: Treatment and Prevention","volume":"8","author":"Zhan","year":"2007","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1600-0625.2012.01516.x","article-title":"Activation of Mitochondrial Apoptosis Pathways in Cutaneous Squamous Cell Carcinoma Cells by Diclofenac\/Hyaluronic Acid Is Related to Upregulation of Bad as Well as Downregulation of Mcl-1 and Bcl-w","volume":"21","author":"Rodust","year":"2012","journal-title":"Exp. Dermatol."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jaad.2016.01.050","article-title":"The Effect of Topical Diclofenac 3% and Calcitriol 3 \u039cg\/g on Superficial Basal Cell Carcinoma (sBCC) and Nodular Basal Cell Carcinoma (nBCC): A Phase II, Randomized Controlled Trial","volume":"75","author":"Brinkhuizen","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2165\/00128071-200304030-00007","article-title":"Topical 3% Diclofenac in 2.5% Hyaluronic Acid Gel: A Review of Its Use in Patients with Actinic Keratoses","volume":"4","author":"Jarvis","year":"2003","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1179\/1973947813Y.0000000117","article-title":"Topical Combination of Diclofenac, Calcipotriol, and Difluoromethylornithine Has Beneficial Effects Comparable to 5-Fluorouracil for the Treatment of Non-Melanoma Skin Cancer in Mice","volume":"26","author":"Pommergaard","year":"2014","journal-title":"J. Chemother."},{"key":"ref_259","first-page":"2049","article-title":"The Combined Effect of CO2 Laser, Topical Diclofenac 3%, and Imiquimod 5% in Treating High-Risk Basal Cell Carcinoma","volume":"21","author":"Saudi","year":"2021","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"25912","DOI":"10.3390\/ijms161025912","article-title":"Combined Treatments with Photodynamic Therapy for Non-Melanoma Skin Cancer","volume":"16","author":"Lucena","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_261","doi-asserted-by":"crossref","unstructured":"Tampucci, S., Carpi, S., Digiacomo, M., Polini, B., Fogli, S., Burgalassi, S., Macchia, M., Nieri, P., Manera, C., and Monti, D. (2019). Diclofenac-Derived Hybrids for Treatment of Actinic Keratosis and Squamous Cell Carcinoma. Molecules, 24.","DOI":"10.3390\/molecules24091793"},{"key":"ref_262","first-page":"40","article-title":"Ingenol Mebutate Gel (Picato): A Novel Agent for the Treatment of Actinic Keratoses","volume":"39","author":"Fidler","year":"2014","journal-title":"Pharm. Ther."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1358\/dot.2013.49.1.1910723","article-title":"Ingenol Mebutate: A New Option for Actinic Keratosis Treatment","volume":"49","author":"Gras","year":"2013","journal-title":"Drugs Today"},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1158\/1535-7163.MCT-15-0023-T","article-title":"Data from Ingenol Mebutate Signals via PKC\/MEK\/ERK in Keratinocytes and Induces Interleukin Decoy Receptors IL1R2 and IL13RA2","volume":"14","author":"Freiberger","year":"2023","journal-title":"Mol. Cancer Ther."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"8123","DOI":"10.4049\/jimmunol.177.11.8123","article-title":"Neutrophils Are a Key Component of the Antitumor Efficacy of Topical Chemotherapy with Ingenol-3-Angelate","volume":"177","author":"Challacombe","year":"2006","journal-title":"J. Immunol."},{"key":"ref_266","first-page":"e150","article-title":"Efficacy and Safety of 0.05% Ingenol Mebutate in the Treatment of Basal Cell Carcinoma: A Prospective Study","volume":"3","author":"Velin","year":"2022","journal-title":"Ski. Health Dis."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/jdv.15907","article-title":"Basal Cell Carcinoma Treated with Combined Ablative Fractional Laser and Ingenol Mebutate\u2014An Exploratory Study Monitored by Optical Coherence Tomography and Reflectance Confocal Microscopy","volume":"34","author":"Banzhaf","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_268","doi-asserted-by":"crossref","unstructured":"Tan, I.J., Pathak, G., and Silver, F.H. (2023). Topical Treatments for Basal Cell Carcinoma and Actinic Keratosis in the United States. Cancers, 15.","DOI":"10.3390\/cancers15153927"},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5021\/ad.2020.32.1.47","article-title":"Comparison of the Treatment Outcomes of Photodynamic Therapy and Ingenol Mebutate in Bowen\u2019s Disease: A Retrospective Observational Study","volume":"32","author":"An","year":"2020","journal-title":"Ann. Dermatol."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2310\/7750.2012.12050","article-title":"Mebutate: A Promising Treatment for Actinic Keratoses and Nonmelanoma Skin Cancers","volume":"17","author":"Gupta","year":"2013","journal-title":"J. Cutan. Med. Surgery"},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000447391","article-title":"Ingenol Mebutate 150 Mg as Physician-Directed Treatment of Bowen\u2019s Disease Under Occlusion","volume":"232","author":"Alkhalaf","year":"2016","journal-title":"Dermatology"},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/12034754221143091","article-title":"Ingenol Mebutate Is Associated With Increased Reporting Odds for Squamous Cell Carcinoma in Actinic Keratosis Patients, a Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)","volume":"27","author":"Jedlowski","year":"2022","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"e14114","DOI":"10.1111\/dth.14114","article-title":"Retrospective Analysis of Squamous Cell Carcinoma Associated with Ingenol Mebutate Reported to the US Food and Drug Administration","volume":"33","author":"Wang","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_274","first-page":"633","article-title":"The Sap from Euphorbia Peplus Is Effective against Human Nonmelanoma Skin Cancers","volume":"164","author":"Ramsay","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1126\/science.1241606","article-title":"14-Step Synthesis of (+)-Ingenol from (+)-3-Carene","volume":"341","author":"McKerrall","year":"2013","journal-title":"Science"},{"key":"ref_276","doi-asserted-by":"crossref","unstructured":"Tang, H., Yusuff, N., and Wood, J.L. (2001). Progress Toward the Total Synthesis of Ingenol: Construction of the Complete Carbocyclic Skeleton. ChemInform, 32.","DOI":"10.1002\/chin.200135254"},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"5624","DOI":"10.1016\/j.bmcl.2013.08.038","article-title":"Syntheses, Biological Evaluation and SAR of Ingenol Mebutate Analogues for Treatment of Actinic Keratosis and Non-Melanoma Skin Cancer","volume":"23","author":"Liang","year":"2013","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s13555-016-0137-2","article-title":"Ingenol Disoxate: A Novel 4-Isoxazolecarboxylate Ester of Ingenol with Improved Properties for Treatment of Actinic Keratosis and Other Non-Melanoma Skin Cancers","volume":"6","author":"Bertelsen","year":"2016","journal-title":"Dermatol. Ther."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4161\/derm.17534","article-title":"Vitamin D Analogs in the Treatment of Psoriasis: Where Are We Standing and Where Will We Be Going?","volume":"3","author":"Reichrath","year":"2011","journal-title":"Dermatoendocrinology"},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/phpp.12893","article-title":"Comparative Evaluation of Efficacy and Safety of Calcipotriol versus Calcitriol Ointment, Both in Combination with Narrow-Band Ultraviolet B Phototherapy in the Treatment of Stable Plaque Psoriasis","volume":"39","author":"Chakraborty","year":"2023","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"e125476","DOI":"10.1172\/jci.insight.125476","article-title":"Skin Cancer Precursor Immunotherapy for Squamous Cell Carcinoma Prevention","volume":"4","author":"Rosenberg","year":"2019","journal-title":"JCI Insight"},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"100104","DOI":"10.1016\/j.xjidi.2022.100104","article-title":"Topical Calcipotriol plus 5-Fluorouracil Immunotherapy for Actinic Keratosis Treatment","volume":"2","author":"Azin","year":"2022","journal-title":"JID Innov."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1172\/JCI89820","article-title":"Randomized Trial of Calcipotriol Combined with 5-Fluorouracil for Skin Cancer Precursor Immunotherapy","volume":"127","author":"Cunningham","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jaad.2020.07.010","article-title":"Cyclic Calcipotriene 0.005% Foam and 1% 5-Fluorouracil Cream after Cryotherapy in Treatment of Hyperkeratotic Actinic Keratosis: A Retrospective Study","volume":"84","author":"Moore","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s40261-024-01392-w","article-title":"Calcipotriol and 5-Fluorouracil Combination Therapy for the Treatment of Actinic Keratosis in the Clinic: A Review Article","volume":"44","author":"Dlott","year":"2024","journal-title":"Clin. Drug Investig."},{"key":"ref_286","first-page":"10077","article-title":"Calcipotriol as a Daylight Photodynamic Therapy Enhancer: A Case-Control Study","volume":"17","author":"Sonego","year":"2024","journal-title":"Dermatol. Rep."},{"key":"ref_287","first-page":"1357","article-title":"Roles of Solar UVB and Vitamin D in Reducing Cancer Risk and Increasing Survival","volume":"36","author":"Grant","year":"2016","journal-title":"Anticancer Res."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc3691","article-title":"The role of vitamin D in reducing cancer risk and progression","volume":"14","author":"Feldman","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.2741\/1731","article-title":"Vitamin D and cancer: An update of in vitro and in vivo data","volume":"10","author":"Larriba","year":"2005","journal-title":"Front. Biosci."},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jsbmb.2017.06.013","article-title":"On the role of classical and novel forms of vitamin D in melanoma progression and management","volume":"177","author":"Slominski","year":"2018","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_291","doi-asserted-by":"crossref","unstructured":"Podgorska, E., Drzal, A., Matuszak, Z., Swakon, J., Slominski, A., Elas, M., and Urbanska, K. (2018). Calcitriol and Calcidiol Can Sensitize Melanoma Cells to Low\u2013LET Proton Beam Irradiation. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19082236"},{"key":"ref_292","doi-asserted-by":"crossref","unstructured":"Tatiya, A., Patil, J., Girase, T., Patil, M., and Patel, K. (2023). An Overview on Management of Psoriasis Using Calcipotriene and Its Amalgamation as Nano Based Drug Delivery System. Mater. Proc., 14.","DOI":"10.3390\/IOCN2023-14504"},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1080\/01932691.2024.2325395","article-title":"Topical Co-Delivery of Tacrolimus and Calcipotriol Loaded Nanostructured Lipid Carrier: A Potential and Synergistic Approach in the Management of Psoriasis","volume":"46","author":"Parveen","year":"2024","journal-title":"J. Dispers. Sci. Technol."},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"102168","DOI":"10.1016\/j.jddst.2020.102168","article-title":"Statistically Optimized Calcipotriol Fused Nanostructured Lipid Carriers for Effectual Topical Treatment of Psoriasis","volume":"61","author":"Pradhan","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s40257-021-00594-8","article-title":"50 Years of Topical Retinoids for Acne: Evolution of Treatment","volume":"22","author":"Baldwin","year":"2021","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_296","doi-asserted-by":"crossref","unstructured":"Ramchatesingh, B., Mart\u00ednez Villarreal, A., Arcuri, D., Lagac\u00e9, F., Setah, S.A., Touma, F., Al-Badarin, F., and Litvinov, I.V. (2022). The Use of Retinoids for the Prevention and Treatment of Skin Cancers: An Updated Review. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232012622"},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/ijd.12365","article-title":"Acitretin in Psoriasis: An Evolving Scenario","volume":"53","author":"Dogra","year":"2014","journal-title":"Int. J. Dermatol."},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1524-4725.2010.01842.x","article-title":"Retinoids for Chemoprophylaxis of Nonmelanoma Skin Cancer","volume":"37","author":"Carr","year":"2011","journal-title":"Dermatol. Surg."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/jid.2011.483","article-title":"Tretinoin and the prevention of keratinocyte carcinoma (Basal and squamous cell carcinoma of the skin): A veterans affairs randomized chemoprevention trial","volume":"132","author":"Weinstock","year":"2012","journal-title":"J. Investig. Dermatol."},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0190-9622(86)70241-7","article-title":"Topical tretinoin in actinic keratosis and basal cell carcinoma","volume":"15","author":"Peck","year":"1986","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_301","doi-asserted-by":"crossref","unstructured":"Sami, N., Feld, S.d.l., and Wolverton, S.E. (2021). 46-Topical retinoids. Comprehensive Dermatologic Drug Therapy, Elsevier. [4th ed.].","DOI":"10.1016\/B978-0-323-61211-1.00046-2"},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1067\/mjd.2003.451","article-title":"Assessment of adapalene gel for the treatment of actinic keratoses and lentigines: A randomized trial","volume":"49","author":"Kang","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4155\/ppa-2021-0021","article-title":"Drug Repurposing of Adapalene for Melanoma Treatment","volume":"11","year":"2022","journal-title":"Pharm. Pat. Anal."},{"key":"ref_304","doi-asserted-by":"crossref","unstructured":"Rusu, A., Tanase, C., Pascu, G.-A., and Todoran, N. (2020). Recent Advances Regarding the Therapeutic Potential of Adapalene. Pharmaceuticals, 13.","DOI":"10.3390\/ph13090217"},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1089\/dna.2014.2366","article-title":"Tazarotene Induces Apoptosis in Human Basal Cell Carcinoma via Activation of Caspase-8\/t-Bid and the Reactive Oxygen Species-Dependent Mitochondrial Pathway","volume":"33","author":"Wu","year":"2014","journal-title":"DNA Cell Biol."},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1365-2133.2004.06044.x","article-title":"Topical Treatment of Basal Cell Carcinoma with Tazarotene: A Clinicopathological Study on a Large Series of Cases","volume":"151","author":"Bianchi","year":"2004","journal-title":"Br. J. Dermatol."},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1158\/1940-6207.CAPR-13-0305","article-title":"Tazarotene: Randomized, Double-Blind, Vehicle-Controlled and Open-Label Concurrent Trials for Basal Cell Carcinoma Prevention and Therapy in Patients with Basal Cell Nevus Syndrome","volume":"7","author":"Tang","year":"2014","journal-title":"Cancer Prev. Res."},{"key":"ref_308","doi-asserted-by":"crossref","unstructured":"Cosio, T., Di Prete, M., Gaziano, R., Lanna, C., Orlandi, A., Di Francesco, P., Bianchi, L., and Campione, E. (2021). Trifarotene: A Current Review and Perspectives in Dermatology. Biomedicines, 9.","DOI":"10.3390\/biomedicines9030237"},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"0436","DOI":"10.36922\/td.0436","article-title":"An Evidence-Based Review on Bexarotene","volume":"2","author":"Mahajan","year":"2023","journal-title":"Tumor Discov."},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"520","DOI":"10.4103\/0019-5154.164426","article-title":"Alitretinoin in Dermatology-An Update","volume":"60","author":"Bubna","year":"2015","journal-title":"Indian J. Dermatol."},{"key":"ref_311","doi-asserted-by":"crossref","unstructured":"Sallam, M.A., Prakash, S., Krishnan, V., Todorova, K., Mandinova, A., and Mitragotri, S. (2020). Hyaluronic Acid Conjugates of Vorinostat and Bexarotene for Treatment of Cutaneous Malignancies. Adv. Ther., 3.","DOI":"10.1002\/adtp.202000116"},{"key":"ref_312","doi-asserted-by":"crossref","unstructured":"Warda, A., Staniszewski, L.J.P., Sabir, Z.L., Livingston, S., Sausedo, M.A., Reshi, S.M., Ron, E., Applegate, M.T., Haddad, D., and Khamisi, M. (2023). Development of Bexarotene Analogs for Treating Cutaneous T-Cell Lymphomas. Cells, 12.","DOI":"10.3390\/cells12212575"},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijpharm.2007.05.061","article-title":"Solid Lipid Nanoparticles (SLN) of Tretinoin: Potential in Topical Delivery","volume":"345","author":"Shah","year":"2007","journal-title":"Int. J. Pharm."},{"key":"ref_314","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.addr.2018.02.003","article-title":"Combined Use of Nanocarriers and Physical Methods for Percutaneous Penetration Enhancement","volume":"127","author":"Dragicevic","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_315","doi-asserted-by":"crossref","unstructured":"Hafeez, A., and Kazmi, I. (2017). Dacarbazine Nanoparticle Topical Delivery System for the Treatment of Melanoma. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-16878-1"},{"key":"ref_316","doi-asserted-by":"crossref","unstructured":"Bhattacharya, S., and Sharma, S. (2023). Dacarbazine-Encapsulated Solid Lipid Nanoparticles for Skin Cancer: Physical Characterization, Stability, in-Vivo Activity, Histopathology, and Immunohistochemistry. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1102269"},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"124730","DOI":"10.1016\/j.ijpharm.2024.124730","article-title":"Effect of Iontophoresis on Dacarbazine Cutaneous Delivery for Melanoma Topical Treatment","volume":"665","author":"Cardoso","year":"2024","journal-title":"Int. J. Pharm."},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12247-025-09929-y","article-title":"Enhanced Delivery of Dacarbazine Using Nanosponge Loaded Hydrogel for Targeted Melanoma Treatment: Formulation, Statistical Optimization and Pre-Clinical Evaluation","volume":"20","author":"Vankudre","year":"2025","journal-title":"J. Pharm. Innov."},{"key":"ref_319","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s11671-020-3293-3","article-title":"Co-Delivery of Dacarbazine and All-Trans Retinoic Acid (ATRA) Using Lipid Nanoformulations for Synergistic Antitumor Efficacy Against Malignant Melanoma","volume":"15","author":"Li","year":"2020","journal-title":"Nanoscale Res. Lett."},{"key":"ref_320","doi-asserted-by":"crossref","first-page":"20467","DOI":"10.1039\/C4RA16306K","article-title":"Dual Drug Encapsulation in a Novel Nano-Vesicular Carrier for the Treatment of Cutaneous Melanoma: Characterization and in Vitro\/in Vivo Evaluation","volume":"5","author":"Lei","year":"2015","journal-title":"RSC Adv."},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"105417","DOI":"10.1016\/j.jddst.2024.105417","article-title":"Microneedle Pretreatment and Cationic Nanoparticles for Transdermal Delivery of Doxorubicin against Melanoma","volume":"93","author":"Yang","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_322","doi-asserted-by":"crossref","unstructured":"Slavkova, M., Dimitrova, D., Voycheva, C., Popova, T., Spassova, I., Kovacheva, D., Yordanov, Y., Tzankova, V., and Tzankov, B. (2024). Composite Hydrogel with Oleic Acid-Grafted Mesoporous Silica Nanoparticles for Enhanced Topical Delivery of Doxorubicin. Gels, 10.","DOI":"10.3390\/gels10060356"},{"key":"ref_323","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1166\/jbn.2015.2139","article-title":"Topical Skin Cancer Therapy Using Doxorubicin-Loaded Cationic Lipid Nanoparticles and Lontophoresis","volume":"11","author":"Pereira","year":"2015","journal-title":"J. Biomed. Nanotechnol."},{"key":"ref_324","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.scib.2017.11.018","article-title":"Direct Site-Specific Treatment of Skin Cancer Using Doxorubicin-Loaded Nanofibrous Membranes","volume":"63","author":"Guo","year":"2017","journal-title":"Chin. Sci. Bull."},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"105378","DOI":"10.1016\/j.jddst.2024.105378","article-title":"Topical Delivery of Mannose Conjugated-Doxorubicin-Berberine Nanostructured Lipid Carrier Gel for Skin Cancer Amelioration: Formulation Optimization, in-Silico, in-Vitro, Ex-Vivo Assessment, and Dermatokinetic Analysis","volume":"93","author":"Yasmeen","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_326","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.msec.2019.02.095","article-title":"Derma Roller\u00ae Microneedles-Mediated Transdermal Delivery of Doxorubicin and Celecoxib Co-Loaded Liposomes for Enhancing the Anticancer Effect","volume":"99","author":"Ahmed","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"ref_327","doi-asserted-by":"crossref","unstructured":"Ferrari, G., Pang, L.Y., De Moliner, F., Vendrell, M., Reardon, R., Higgins, A.J., Chopra, S., and Argyle, D. (2022). Effective Penetration of a Liposomal Formulation of Bleomycin through Ex-Vivo Skin Explants from Two Different Species. Cancers, 14.","DOI":"10.3390\/cancers14041083"},{"key":"ref_328","doi-asserted-by":"crossref","first-page":"1","DOI":"10.20546\/ijcmas.2024.1304.001","article-title":"Transdermal Delivery of Paclitaxel-Anionic Nanoparticles to Epidermis Layer, Pterostilbene, and Pterostilbene Glycoside, and Their Application for Treatment of Skin Cancer and Wrinkle","volume":"13","author":"Hamada","year":"2024","journal-title":"Int. J. Curr. Microbiol. Appl. Sci."},{"key":"ref_329","doi-asserted-by":"crossref","unstructured":"Tolentino, S., Monteiro, M.M., Saldanha-Ara\u00fajo, F., Cunha-Filho, M., Gratieri, T., Guerra, E.N.S., and Gelfuso, G.M. (2025). Bioadhesive Chitosan Films Loading Curcumin for Safe and Effective Skin Cancer Topical Treatment. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17010018"},{"key":"ref_330","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1208\/s12249-017-0833-y","article-title":"Effective Skin Cancer Treatment by Topical Co-Delivery of Curcumin and STAT3 siRNA Using Cationic Liposomes","volume":"19","author":"Jose","year":"2018","journal-title":"AAPS Pharmscitech"},{"key":"ref_331","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1007\/s13346-024-01534-9","article-title":"Resveratrol-Loaded Invasome Gel: A Promising Nanoformulation for Treatment of Skin Cancer","volume":"14","author":"Samir","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_332","doi-asserted-by":"crossref","first-page":"105659","DOI":"10.1016\/j.jddst.2024.105659","article-title":"Quercetin-Loaded Transliposomal Gel for Effective Management of Skin Cancer: In Vitro and Cell Line Efficacy Studies","volume":"96","author":"Kalam","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_333","doi-asserted-by":"crossref","first-page":"105843","DOI":"10.1016\/j.jddst.2024.105843","article-title":"Development of Nanobigel System Combining Apoptosis-Inducing Daidzein and Flaxseed Oil for the Synergistic Treatment of Skin Cancer","volume":"98","author":"Mangla","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_334","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3897\/pharmacia.72.e143419","article-title":"Anti-Melanoma Activity of Green-Produced Nanosilver-Chlorhexidine Complex","volume":"72","author":"Ivanova","year":"2025","journal-title":"Pharmacia"},{"key":"ref_335","doi-asserted-by":"crossref","first-page":"101882","DOI":"10.1016\/j.jksus.2022.101882","article-title":"Antimicrobial, an-Ti-Melanogenesis and Anti-Tyrosinase Potential of Myco-Synthesized Silver Nanoparticles on Human Skin Melanoma SK-MEL-3 Cells","volume":"34","author":"Himalini","year":"2022","journal-title":"J. King Saud. Univ. Sci."},{"key":"ref_336","doi-asserted-by":"crossref","first-page":"102125","DOI":"10.1016\/j.jsps.2024.102125","article-title":"Development of Topical Silver Nano Gel Formulation of Bixin: Characterization, and Evaluation of Anticancer Activity","volume":"32","author":"Patil","year":"2024","journal-title":"Saudi Pharm. J."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/17\/8\/1009\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:21:05Z","timestamp":1760034065000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/17\/8\/1009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":336,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["pharmaceutics17081009"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics17081009","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]}}}